INTRODUCTION
============

*Streptococcus agalactiae*, a group B *Streptococcus* (GBS), is part of the normal flora of the skin, throat, lower gastrointestinal tract, and female genital tract. It is recognized as a major human pathogen in neonatal sepsis and postpartum infection. However, the incidence of invasive infection by *S. agalactiae* has increased in recent years in non-pregnant adult patients, elderly patients, and patients with chronic immunosuppressive diseases \[[@B1]\]. In particular, GBS endogenous endophthalmitis is an extremely rare but visually devastating disease \[[@B2][@B3][@B4]\]. The clinical profile of GBS endophthalmitis is not well characterized because little literature is available. Here, we report the first South Korean case without evidence of immunosuppression, presenting as endophthalmitis complicating GBS infective endocarditis. Furthermore, we describe the clinical, prognostic, and therapeutic characteristics of 22 patients with this infection in the literature.

CASE REPORT
===========

A previously healthy 43-year-old woman visited our emergency room complaining of a 10-hour history of decreased visual acuity with ocular pain in the right eye. She was taking oral antibiotics (cefaclor) for a skin abscess of the right buttock area, which developed 2 weeks earlier. She also underwent dental scaling 3 months earlier. She underwent a bilateral laser in-situ keratomileusis (LASIK) procedure 10 years earlier, and her final corrected visual acuity was 20/20 in both eyes.

On admission, she had a blood pressure of 120/60 mmHg, heart rate of 88 beats/min, body temperature of 37.9°C, and respiratory rate of 20/min. Physical examination did not reveal a cardiac murmur. No Osler\'s nodes, Janeway lesions, or splinter hemorrhages were observed. There was a 3-cm skin swelling with purulent discharge on the right buttock area that was tender and erythematous. The results of the initial laboratory investigations were normal, except for a leukocyte count of 13.9 × 10^3^/mm^3^, with 74% neutrophils and a C-reactive protein level of 26.7 mg/dL. Ophthalmic examination revealed an initial visual acuity of 20/100 and 20/20 in the right and left eye, respectively. There was full ocular motility. Slit-lamp examination showed severe conjunctival injection and chemosis, total corneal epithelial defect, corneal edema, and keratin precipitate on the corneal endothelium. The anterior chamber was poorly visible because of keratin precipitate and intense fibrinous reaction. Intraocular pressure was 25 and 10 mmHg using Goldman applanation tonometry. The right fundus was poorly visible, and ultrasonography revealed the presence of vitritis. The results of external, slit-lamp, and fundus examinations of the left eye were normal. Clinical samples of blood, the aqueous humor of the right eye, and discharge from the buttock lesion were obtained on admission. Gram-positive cocci in chains was cultured from all of these samples, and the patient was diagnosed with endogenous endophthalmitis of the right eye as well as a skin and soft tissue infection on the right buttock secondary to streptococcal sepsis. Initial transthoracic echocardiography was normal. For the first 12 days of hospitalization, before infective endocarditis was confirmed, intravenous ceftriaxone (2 g/day) was prescribed as an empirical and definite antibiotic therapy with a regimen of intravitreal vancomycin (1 mg/0.1 mL) and ceftazidime (2.25 mg/0.1 mL).

Despite intravitreal vancomycin and ceftazidime injection, her visual acuity rapidly deteriorated to light perception within a day. On the third day of hospitalization, she underwent right core vitrectomy, which revealed a pus-filled vitreous cavity. Culture of the vitreous humor was performed. Group B β-hemolytic streptococci (*S. agalactiae*) was identified as the causative organism in the vitreous specimen, blood, and skin pus of the right buttock, using a VITEK II system (bioMérieux, Hazelwood, MO, USA), with a probability of 99.0%. The GBS was highly susceptible to penicillin, vancomycin, and cephalosporins according to the Clinical Laboratory Standards Institute (CLSI) guidelines. Ten days after initial transthoracic echocardiography, transesophageal echocardiography revealed a 5-mm vegetation to the anterior mitral leaflet. The patient was finally diagnosed with an invasive GBS infection with infective endocarditis presenting with endogenous endophthalmitis and a skin and soft tissue infection. A MicroScan MICroSTREP plus panel was used to determine antimicrobial susceptibility and measure minimum inhibitory concentrations. The results showed susceptibility to penicillin (0.06 μg/mL), ampicillin (0.12 μg/mL), ceftriaxone (0.25 μg/mL), cefotaxime (0.25 μg/mL), cefepime (0.25 μg/mL), meropenem (0.12 μg/mL), azithromycin (0.25 μg/mL), clindamycin (0.06 μg/mL), vancomycin (0.5 μg/mL), and levofloxacin (0.5 μg/mL). To further confirm the identity of this isolate, sequencing of a 438-base pair 16S rRNA gene fragment according to CLSI recommendations revealed a 97% identity match to *S. agalactiae* strain sequence type 1 (SS1) associated with serotype V (accession number: CP010867.1). According to the clinical guidelines under the clinical diagnosis of infective endocarditis, intravenous ampicillin (3 g q6 hrs) and gentamicin (5.1 mg/kg q24 hrs) were administered for 28 and 14 days, respectively, with intravitreal antibiotic therapy \[[@B5]\]. The patient was discharged after completing the 28-day intravenous ampicillin treatment. At the 6-month follow-up visit after the completion of antibiotic therapy, the patient remained free of complications from infective endocarditis or skin and soft tissue infection. She had no infectious signs on her right eye but had lost perception to light, and phthisis bulbi had developed.

DISCUSSION
==========

Endophthalmitis is defined as an internal infection of the eye involving the vitreous or aqueous humor that can be classified as either endogenous or exogenous depending on the route of infection. Exogenous bacterial endophthalmitis occurs most commonly, generally after penetrating ocular trauma, intraocular surgery, or a corneal ulcer. However, endogenous endophthalmitis, also known as metastatic endophthalmitis, can arise from hematogenous spread of bacteremia or other remote septic foci. Endogenous endophthalmitis accounts for only 5--7% of endophthalmitis cases and has a high mortality rate of up to 29% with poor visual acuity outcomes \[[@B6]\]; it is associated with underlying medical conditions such as diabetes or cardiac diseases and malignancy in up to 90% of patients \[[@B7]\]. However, the present endogenous endophthalmitis patient was a middle-aged immunocompetent woman with no evidence of underlying disease.

Systemic infections such as liver abscesses, meningitis, and infective endocarditis may subsequently develop endogenous endophthalmitis. The present patient was diagnosed with infective endocarditis. However, this was likely due to bacteremia rather than the source of sepsis. Considering her oral antibiotic treatment for a skin abscess on the right buttock without systemic symptoms for 2 weeks, the skin and soft tissue infection may be regarded as the primary infection focus that caused GBS bacteremia complicated with infective endocarditis. Although the patient underwent dental scaling prior to infection, there was no evidence that dental scaling increased her risk of infective endocarditis.

Infective endocarditis caused by *S. agalactiae* is an uncommon but aggressive disease with a high mortality rate of \~40% \[[@B8]\]. It is generally characterized by an acute onset, the presence of large vegetations, rapid valvular destruction, and frequent development of complications. Therefore, it is considered very different from infective endocarditis caused by other Streptococci. However, there is limited information regarding metastatic endophthalmitis.

Endogenous endophthalmitis caused by GBS is very rare in non-pregnant adults, accounting for only 5.2% of bacterial endogenous endophthalmitis cases, only 21 of which have been reported in the literature worldwide \[[@B2] [@B9][@B10][@B11][@B12][@B13][@B14][@B15][@B16][@B17][@B18][@B19]\]. In contrast to the present case, 18 (85.7%) of these 21 cases had predisposing factors such as old age, diabetes mellitus, cardiac diseases, malignant diseases, and immunosuppression ([Table 1](#T1){ref-type="table"}). Including the present case, the most common septic focus was skin and soft tissue infection (n = 5, 22.7%) followed by septic arthritis (n = 3; 13.6%), urinary tract infection (n = 3; 13.6%), central nervous system infection (n = 2; 9.0%), pharyngitis (n = 2; 9.0%), pneumonia (n = 2; 9.0%), or no evident foci of infection (n = 5; 22.7%). Among them, 5 (18.1%) cases exhibited infective endocarditis, but none exhibited vegetation in the initial transthoracic echocardiography. The present case exhibited cardiac vegetation in the transesophageal echocardiography 7 days after the initial transthoracic echocardiography. Therefore, transesophageal echocardiography should be recommended for patients with endogenous endophthalmitis caused by GBS. Septic arthritis (n = 10, 45.4%) was one of the most common manifestations in previously reported cases of endophthalmitis secondary to GBS; this may be because of the role of the synovial space and vitreous humor as culture media for facilitating bacterial seeding, entrapment, and proliferation \[[@B11]\].

###### Clinical characteristics and treatment outcomes of 22 cases of endogenous endophthalmitis due to *Streptococcus agalactiae*

![](ic-49-286-i001)

  Ref            Country    Sex/age   Predisposing illness                 Infection source                 Other sites of infection             Time to eye signs   Laterality & visual acuity   Type of endophthalmitis          Culture (B/V)   Other culturepositive sites   Vitrectomy   Intravitreal antibiotics   Systemic antibiotics                        Visual outcome        Serotype
  -------------- ---------- --------- ------------------------------------ -------------------------------- ------------------------------------ ------------------- ---------------------------- -------------------------------- --------------- ----------------------------- ------------ -------------------------- ------------------------------------------- --------------------- ----------
  \[[@B2]\]      Malaysia   M/55      None                                 Foot abscess                     Septic arthritis                     2 weeks             OS-LP                        Diffuse                          +/−             Foot abscess                  \+           Vancomycin, gentamicin     Vancomycin, penicillin                      Phthisis bulbi        
  \[[@B2]\]      China      M/67      None                                 Cervical epidural abscess        Osteomyelitis                        1 week              OS-CF                        Posterior                        +/+                                           \+           Vancomycin, gentamicin     Penicillin                                  Phthisis bulbi        
  \[[@B2]\]      China      M/53      DM                                   Septic arthritis                 Septic arthritis                     5 days              OD-LP                        Diffuse                          +/+             Knee synovial aspirate        −            Vancomycin, ceftazidime    Penicillin, gentamicin                      Evisceration          
  \[[@B2]\]      China      M/82      DM                                   Unknown                          Septic arthritis                     Concurrent          OD-NLP                       Diffuse                          +/+                                           −            Vancomycin, ceftazidime    Penicillin, ciprofloxacin                   Phthisis bulbi        
  \[[@B2]\]      China      F/63      None                                 Unknown                          Septic arthritis                     2 days              OD-LP                        Diffuse                          +/+                                           −            Vancomycin, amikacin       Ceftriaxone                                 Phthisis bulbi        
  \[[@B3]\]      USA        M/42      Congenital heart disease             Pharyngitis                      Infective endocarditis               10 days             OD-LP                        Posterior                        +/NA                                                       NA                         Cefazolin, gentamicin, penicillin           Died                  
  \[[@B4]\]      Canada     F/80      AF, HTN, Knee prosthesis             Unknown                          Infective endocarditis, meningitis   12 hours            OS-LP                        Diffuse                          +/+             CSF                           −            NA                         NA                                          Died                  
  \[[@B9]\]      Japan      M/83      None                                 Pneumonia                        None                                 4 days              OD-LP, OS-NLP                Posterior                        −/+             Aqueous                       −            NA                         Ceftazidime                                 Enucleated            
  \[[@B10]\]     UK         M/55      Renal canaliculi, multiple myeloma   UTI                              Septic arthritis                     Concurrent          OD-HM, OS-6/36               Posterior, diffuse               +/+             Aqueous                       −            Cefuroxime                 Amoxicillin, gentamicin                     LP, 6/6               Ib
  \[[@B10]\]     UK         F/76      None                                 UTI                              Pneumonia                            2 days              OD-LP, OS-NLP                OS-Pan                           +/NA            Urine, conjunctiva            −            NA                         Benzylpenicillin, gentamicin, acyclovir     LP, NLP               Ib/c
  \[[@B10]\]     UK         M/65      DM                                   Septic arthritis                 Infective endocarditis               Concurrent          OD-LP, OS-6/5                OD-Posterior diffuse, OS-Focal   +/+             Kneeaspirate                  −            Cefuroxime                 Amoxicillin, gentamicin, Benzylpenicillin   Phthisis bulbi, 6/5   Ib
  \[[@B10]\]     UK         M/60      None                                 Pharyngitis                      Septic arthritis                     Concurrent          OS-6/60                      Pan                              +/NA                                                       NA                         Benzylpenicillin, gentamicin                Evisceration          Ia/c
  \[[@B11]\]     China      F/95      None                                 Pneumonia                        None                                 3 days              OS-NLP                       Diffuse                          +/NA                                          \+           Vancomycin, ceftazidime    Ampicillin/sulbactam, vancomycin            OU-NLP                
  \[[@B12]\]     UK         F/70      None                                 Unknown                          Septic arthritis                     4 days              OD-6/18, OS-6/36             NA                               +/NA            Synovial aspirate                          NA                         Benzylpenicillin                            OU-Recovery           V
  \[[@B13]\]     Canada     F/74      None                                 Cellulitis, Chronic foot ulcer   None                                 2 days              OS-LP                        Posterior                        NA/+            Foot ulcer pus                \+           Vancomycin, amikacin       Cefazolin, gentamicin                       Phthisis bulbi        
  \[[@B14]\]     USA        F/62      DM, HTN                              Cellulitis                       None                                 1 weeks             OD-20/70, OS-LP              Diffuse                          +/+             Foot tissue                   −            Vancomycin, amikacin       Penicillin G                                LP, 20/100            
  \[[@B14]\]     USA        M/48      HIV, Splenectomy                     Meningitis                       None                                 2 day               OD-CF                        Pan                              +/NA            CSF                                                                   Penicillin G                                NLP                   
  \[[@B15]\]     USA        F/75      None                                 Septic arthritis                 Infective endocarditis               20 days             OD-20/70                     Posterior                        +/NA            Urine                         −            NA                         Vancomycin, ceftriaxone, Clindamycin        NA                    
  \[[@B16]\]     USA        M/56      Leukemia                             Unknown                          None                                 3 days              OD-LP                        Diffuse                          +/+             Aqueous                       \+           Vancomycin, amikacin       Vancomycin, clindamycin. Cefotaxime         LP                    
  \[[@B17]\]     USA        F/81      HTN                                  UTI                              None                                 3 days              OD-20/400                    Diffuse                          +/+                                           \+           Vancomycin                 Vancomycin, amikacin, amphotericin          20/200                
  \[[@B18]\]     USA        F/61      DM, HTN, MI                          Endarteritis                     Septic arthritis                     12 days             OU-Not sited.                OD-Anterior, focal OS-Diffuse    +/+             Synovial aspirate             \+           NA                         Penicillin                                  OS-NLP                
  Present case   Korea      F/43      None                                 Cellulitis                       Infective endocarditis               2 weeks             OD-20/100                    Pan                              +/+             Pus of hip abscess            \+           Vancomycin, ceftazidime    Ceftriaxone, gentamycin, ampicillin         Phthisis bulbi        V

Ref, reference; B, blood culture; V, vitreous culture; M, male; OS, left eye; LP, perception of light; CF, counting fingers; DM, diabetes mellitus; OD, right eye; NLP, no perception of light; F; female; NA, net applicable; AF, atrial fibrillation; HTN, hypertension; CSF, cerebrospinal fluid; UTI, urinary tract infection; HM, hand motion; OU, both eye; HIV, human immunodeficiency virus; MI, myocardial infarction.

Previous cases of endophthalmitis secondary to GBS exhibited dramatic loss of vision within a few hours to a few days; this rapid progression is associated with the virulence of GBS. Hemolytin and cytolysin produced by GBS may result in the development of the necrotic vitreous cavity, total retinal detachment, and microabscesses on the choroid \[[@B2]\]; this eventually leads to poor visual prognosis despite prompt antibiotic therapy and surgical intervention such as in the present case.

*S. agalactiae* is classified as serotype Ia/c, Ia/b, II, III, IV, V, VI, VII, or VIII. GBS serotypes Ia, III, and V account for more than two-thirds of cases \[[@B20]\]. The present patient had serotype V, which accounts for \>25% of cases of invasive GBS infection \[[@B20]\].

The most important component in the treatment of endogenous endophthalmitis caused by GBS is prompt and appropriate systemic antibiotic therapy. Unlike exogenous endophthalmitis with a relatively intact blood--ocular barrier, endogenous endophthalmitis has a disrupted barrier due to the transmural passage of the hematogenously spreading organism \[[@B19]\]. Consequently, intravenous antibiotics can easily reach the ocular tissue with endogenous endophthalmitis and the primary infection site. On the contrary, intravitreal antibiotic injection has not been shown to be an effective treatment for endogenous endophthalmitis. However, it may be reasonable to select intravitreal antibiotics on a case-by-case basis, because the existing negative perception could be a consequence of selection bias \[[@B19]\]. Therapeutic vitrectomy can be 3 times more beneficial in retaining useful vision and decreasing the requirement of evisceration or enucleation \[[@B19]\]. However, the advantages of vitrectomy can be limited, because GBS causes rapid and extensive destruction of ocular structure in the early stage of infection, such as in the present case. In the literature, of the 9 eyes that underwent vitrectomy, 7 developed phthisis bulbi and loss of light perception. Although most patients recovered from GBS sepsis (except 2 cases of death; fatality rate: 9.0%), the visual outcome is poor in most patients. Among 30 cases, 22 involved the eyes, in which only 7 eyes recovered useful vision while the others had either only light perception or no light perception and phthisis bulbi.

In conclusion, the present case suggests GBS infections should be included in the differential diagnosis of endogenous endophthalmitis in healthy adults. The present case also highlights the requirement of a high index of suspicion for infective endocarditis in patients despite normal results from initial transthoracic echocardiography. Aggressive antibiotics and surgical therapy may be needed in these cases because of rapid and extensive ocular destruction in the early stage of infection.
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